Annual Gene Therapy Symposium for
Heart, Lung, and Blood Diseases
Home
Information for
Trainees
Register Online
2017
Past Symposia:
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002

UC Davis

 


11th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases
Focus Topic: Translation and Clinical Trials
November 14-16, 2012 - Sonoma, California

Program

 
 

Wednesday, November 14, 2012 - Welcoming Reception

Thursday, November 15, 2012

Keynote Speaker

  • Luigi Naldini, M.D., Ph.D. (San Raffaele Telethon Institute for Gene Therapy)

    “Genetic Engineering of Human Hematopoiesis for Treating Inherited Diseases and Cancer”

Session I: Vectors  

  • Kenneth G. Cornetta, M.D. (Indiana University)
    “The Destiny of Lentiviral Vectors - Research Oddity or FDA Approved Treatment?"”
  • David Schaffer, Ph.D. (UC Berkeley)
    “Directed Evolution of New Viruses for Therapeutic Gene Delivery”
  • Bruce Sullenger, Ph.D. (Duke University)
    “Driving Innovation by Forward and Reverse Translation of Aptamers”
Student/Fellow Presentations and Poster Session - Link to Information

Session II   

  • John P. Cooke, M.D., Ph.D. (Stanford University)
    “Nuclear Programming to Pluripotency Requires Activation of Innate Immunity Pathways: An Overlooked Effect of Viral Vectors Leads to New Reprogramming Approach”
  • Emerson C. Perin, M.D. Ph.D. (Texas Heart Institute)
    “Translational Issues for Cardiovascular Stem Cell Trials: Focus on Delivery”
  • Roger J. Hajjar, M.D. (Mount Sinai School of Medicine)
    “Gene Therapy for the Treatment of Heart Failure”

“Practical Strategies”: Endothelial Progenitors

  • Mervin C. Yoder, M.D. (Indiana University)

Dinner at the Markham Winery

Friday, November 16, 2012

Workshop: “Translation to Clinical Trials”

Student/Fellow Presentations and Poster Session - Link to Information

Session III

  • Paula M. Cannon, Ph.D. (University of Southern California)
    “Pre-Clinical Evaluation of Anti-HIV Gene Therapies in Humanized Mice”
  • Donald B. Kohn, M.D. (University of California, Los Angeles)
    “Gene Therapy Using Hematopoietic Stem Cells”

  • Barry J. Byrne, M.D., Ph.D. (University of Florida)
    "Treatment Strategies for Pompe Disease: Lessons from Preclinical and Clinical Studies"

 
 

Supported by the National Heart, Lung, and Blood Institute, National Institutes of Health. Additional support provided by the National Institute of Allergy and Infectious Diseases (NIAID), NIH; California Institute for Regenerative Medicine (CIRM); California National Primate Research Center; and the UC Davis Clinical and Translational Science Center.